A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood
NCT06419660 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2025-01-22
Summary
The main objective of this trial is to investigate the effect of the proton pump inhibitor esomeprazole on the pharmacokinetics of BI 3000202 in plasma.
Conditions
- Healthy
Interventions
- DRUG
-
BI 300202
BI 300202
- DRUG
-
esomeprazole
esomeprazole
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-05-22
- Primary Completion
- 2024-07-08
- Completion
- 2024-07-08
Countries
- Germany
Study Locations
More Related Trials
-
Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition
NCT06233097 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv
NCT00626262 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of IBI351 in Healthy Subjects
NCT05688124 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Torrent Pharmaceutical Ltd's Esomeprazole Magnesium Delayed Release Capsules
NCT02680132 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)
NCT00626535 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
NCT00352261 ·Status: COMPLETED ·Phase: PHASE4
-
Bioequivalence of Two Formulations of Esomeprazole
NCT02543606 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants
NCT06991179 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions
NCT02659683 ·Status: COMPLETED ·Phase: PHASE1
-
Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome
NCT00079833 ·Status: COMPLETED ·Phase: PHASE3
-
BE of Torrent's Esomeprazole Mg DR Capsules
NCT02680119 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Evaluate the Effect of the Proton Pump Inhibitor Esomeprazole on the Single-dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants
NCT03849690 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Emraclidine in Healthy Adult Participants
NCT06366243 ·Status: COMPLETED ·Phase: PHASE1
-
Esomeprazole Bioavailability Study With 40 mg Oral Single Dose Fasted and Fed Administration
NCT00889850 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant
NCT06275841 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of Isavuconazole
NCT02128893 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.
NCT00206245 ·Status: COMPLETED ·Phase: PHASE2
-
PK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400
NCT00599404 ·Status: COMPLETED ·Phase: PHASE1
-
Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition
NCT06233149 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Investigate the Relative Bioavailability of 2 Different Formulations of AZD4144, the Effect of Food and Omeprazole on the Pharmacokinetics of AZD4144 in Healthy Participants
NCT06948006 ·Status: COMPLETED ·Phase: PHASE1
-
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
NCT00474903 ·Status: COMPLETED ·Phase: PHASE2
-
Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory Drugs
NCT00443963 ·Status: WITHDRAWN ·Phase: PHASE4
-
Drug Drug Interaction Study Of Crizotinib With Esomeprazole.
NCT01549574 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study to Evaluate the Bioequivalence of a Test Formulation Compared to an Equivalent Dose of a Reference Drug Product
NCT02444507 ·Status: UNKNOWN ·Phase: PHASE4
-
Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg
NCT01163630 ·Status: COMPLETED ·Phase: PHASE1